NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 156 filers reported holding NEVRO CORP in Q2 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,534,059 | -26.6% | 217,705 | +4.4% | 0.01% | -28.6% |
| Q1 2023 | $7,541,431 | -6.8% | 208,615 | +2.1% | 0.01% | -12.5% |
| Q4 2022 | $8,092,259 | -16.7% | 204,350 | -1.9% | 0.01% | -20.0% |
| Q3 2022 | $9,709,000 | +6.8% | 208,353 | +0.4% | 0.01% | +11.1% |
| Q2 2022 | $9,092,000 | -14.9% | 207,438 | +40.5% | 0.01% | +12.5% |
| Q1 2022 | $10,682,000 | -57.9% | 147,683 | -52.8% | 0.01% | -50.0% |
| Q4 2021 | $25,349,000 | -42.5% | 312,684 | -17.5% | 0.02% | -44.8% |
| Q3 2021 | $44,096,000 | -35.8% | 378,901 | -8.5% | 0.03% | -35.6% |
| Q2 2021 | $68,633,000 | +39.0% | 413,975 | +17.0% | 0.04% | +25.0% |
| Q1 2021 | $49,363,000 | -18.1% | 353,855 | +1.6% | 0.04% | -16.3% |
| Q4 2020 | $60,275,000 | +17.1% | 348,208 | -5.8% | 0.04% | +4.9% |
| Q3 2020 | $51,465,000 | +169.1% | 369,452 | +130.8% | 0.04% | +141.2% |
| Q2 2020 | $19,124,000 | +22.4% | 160,077 | -60.1% | 0.02% | 0.0% |
| Q4 2018 | $15,621,000 | -81.7% | 401,681 | -73.2% | 0.02% | -78.5% |
| Q3 2018 | $85,560,000 | -36.6% | 1,501,045 | -11.2% | 0.08% | -40.2% |
| Q2 2018 | $135,008,000 | +12.7% | 1,690,765 | +22.3% | 0.13% | +10.9% |
| Q1 2018 | $119,846,000 | +35.3% | 1,382,785 | +7.8% | 0.12% | +36.8% |
| Q4 2017 | $88,570,000 | -14.4% | 1,282,874 | +12.6% | 0.09% | -17.9% |
| Q3 2017 | $103,504,000 | +22.1% | 1,138,912 | -0.0% | 0.11% | +17.8% |
| Q2 2017 | $84,785,000 | +33.0% | 1,139,119 | +67.5% | 0.09% | +32.4% |
| Q1 2017 | $63,734,000 | +31.5% | 680,194 | +2.0% | 0.07% | +25.9% |
| Q4 2016 | $48,456,000 | -20.0% | 666,888 | +14.9% | 0.05% | -16.9% |
| Q3 2016 | $60,606,000 | +5.6% | 580,569 | -25.4% | 0.06% | +3.2% |
| Q2 2016 | $57,391,000 | +15.0% | 778,079 | -12.2% | 0.06% | +21.2% |
| Q1 2016 | $49,884,000 | +112.5% | 886,667 | +155.0% | 0.05% | +126.1% |
| Q4 2015 | $23,473,000 | +55.0% | 347,699 | +6.5% | 0.02% | +43.8% |
| Q3 2015 | $15,142,000 | +106.0% | 326,410 | +138.7% | 0.02% | +128.6% |
| Q2 2015 | $7,351,000 | +5.8% | 136,760 | -5.6% | 0.01% | +16.7% |
| Q1 2015 | $6,947,000 | +22.3% | 144,946 | -1.3% | 0.01% | +20.0% |
| Q4 2014 | $5,680,000 | – | 146,875 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
| Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
| PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
| Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
| Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
| Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
| K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
| Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
| Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
| ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |